Magnitude Biosciences
PrivateLast Round
Venture -
Series Unknown
May 27, 2025
Total Funding Raised
$2.03M
Company Overview
Magnitude Biosciences is a specialist contract research organization (CRO) that spun out of Durham University in 2018. The company provides a patented in-vivo testing platform that uses the nematode worm C. elegans and automated imaging technology to accelerate research and development. This service offers rapid, cost-effective, and high-throughput insights into a compound's efficacy and toxicity, serving as an ethical and efficient alternative to traditional mammalian models. Magnitude Biosciences primarily supports clients in the pharmaceutical, biotechnology, nutraceutical, and academic sectors, with key research areas including aging, neurodegeneration, the microbiome, and toxicity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Healthcare Analytics, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Magnitude Biosciences Comps
Public and private peers based on sector, stage, and business model.
Magnitude Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Venture - Series Unknown | May 27, 2025 | ||||
| Grant | Jun 5, 2023 | ||||
| Seed | Nov 14, 2022 | ||||
| Convertible Debt | Aug 19, 2020 | ||||
| Seed | Dec 2, 2019 | ||||
Seed | Jan 17, 2019 |
Magnitude Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Future Fund | Convertible Debt |
| Maven VCTs | Venture - Series Unknown |
| Innovate UK | Grant, Venture - Series Unknown |
| Saker Capital LLP | Seed |
| Northstar Ventures | Grant, Convertible Debt, Seed, Venture - Series Unknown |
| Innovate UK | Venture - Series Unknown |
| Northern Powerhouse Investment Fund | Venture - Series Unknown |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2025
$943K raised in an unknown series round.
Magnitude Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Magnitude Biosciences's valuation, stock price, and market status.
